<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Res Cardiovasc Med</journal-id><journal-id journal-id-type="iso-abbrev">Res Cardiovasc Med</journal-id><journal-id journal-id-type="doi">10.5812/cardiovascmed</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Research in Cardiovascular Medicine</journal-title></journal-title-group><issn pub-type="ppub">2251-9572</issn><issn pub-type="epub">2251-9580</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26949691</article-id><article-id pub-id-type="pmc">4756256</article-id><article-id pub-id-type="doi">10.5812/cardiovascmed.31378</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The Effects of Side Branch Predilation During Provisional Stenting of Coronary Bifurcation Lesions: A Double-Blind Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Peighambari</surname><given-names>Mohammadmehdi</given-names></name><xref ref-type="aff" rid="aff77632">1</xref></contrib><contrib contrib-type="author"><name><surname>Sanati</surname><given-names>Hamidreza</given-names></name><xref ref-type="aff" rid="aff77632">1</xref><xref ref-type="corresp" rid="cor77633">*</xref></contrib><contrib contrib-type="author"><name><surname>Hadjikarimi</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff77632">1</xref></contrib><contrib contrib-type="author"><name><surname>Zahedmehr</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="aff77632">1</xref></contrib><contrib contrib-type="author"><name><surname>Shakerian</surname><given-names>Farshad</given-names></name><xref ref-type="aff" rid="aff77632">1</xref></contrib><contrib contrib-type="author"><name><surname>Firouzi</surname><given-names>Ata</given-names></name><xref ref-type="aff" rid="aff77632">1</xref></contrib><contrib contrib-type="author"><name><surname>Kiani</surname><given-names>Reza</given-names></name><xref ref-type="aff" rid="aff77632">1</xref></contrib><contrib contrib-type="author"><name><surname>Sadeghipour</surname><given-names>Parham</given-names></name><xref ref-type="aff" rid="aff77632">1</xref></contrib><contrib contrib-type="author"><name><surname>Kzaemi Asl</surname><given-names>Siamak</given-names></name><xref ref-type="aff" rid="aff77634">2</xref></contrib></contrib-group><aff id="aff77632"><label>1</label>Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff77634"><label>2</label>Centers of Excellence Secretariat, Ministry of Health and Education of Iran, Tehran, IR Iran</aff><author-notes><corresp id="cor77633"><label>*</label>Corresponding author: Hamidreza Sanati, Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Vali-e-Asr St., Niayesh Blvd, Tehran, IR Iran. Tel: +98-21239212178; 98-9123765828, Fax: +98-2122055594, E-mail: <email>Sanati56@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>3</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2016</year></pub-date><volume>5</volume><issue>2</issue><elocation-id>e31378</elocation-id><history><date date-type="received"><day>09</day><month>7</month><year>2015</year></date><date date-type="rev-recd"><day>18</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>01</day><month>9</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>There is a paucity of data regarding the role of side branch (SB) predilation during the provisional stenting of bifurcation lesions.</p></sec><sec><title>Objectives:</title><p>The present study aimed to assess the effects of SB predilation on the outcomes of true bifurcation interventions.</p></sec><sec><title>Patients and Methods:</title><p>Sixty patients with true bifurcation lesions according to the Medina classification were included in the study and randomly assigned to receive SB predilation before stenting the main branch (n = 30) or no predilation as the control group (n = 30).</p></sec><sec><title>Results:</title><p>There was a trend toward the higher occurrence of dissection in the predilated ostial lesions of the SB compared to the non-predilated group (16.7% vs. 0, P = 0.07). Performance of the SB predilation was not associated with improved flow of the SB or fewer degrees of ostial stenosis after stenting the main branch, the need to rewire, rewiring time, or the rate of use of the final kissing balloon dilation and double stents procedures.</p></sec><sec><title>Conclusions:</title><p>Routine predilation of the SB in provisional stenting of true bifurcation lesions seems to be ineffective and might be associated with some undesirable consequences. Still, there are some complex ostial lesions of the SB which could benefit from predilation.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Coronary Artery Disease</kwd><kwd>Coronary Artery Stenting</kwd><kwd>Percutaneous Coronary Intervention</kwd></kwd-group></article-meta></front><body><sec id="sec139983"><title>1. Background</title><p>Coronary bifurcation atherosclerotic lesions are quite common as a result of anatomical reasons and resultant flow-dependent alternations leading to pro-atherogenous low wall shear stress (<xref rid="A31378R1" ref-type="bibr">1</xref>). The presence of a bifurcation lesion increases the complexity of percutaneous coronary intervention (PCI) and affects the results of the procedure, including lower rates of success, higher cost, and higher rates of periprocedural myocardial infarction (MI), restenosis and stent thrombosis (<xref rid="A31378R2" ref-type="bibr">2</xref>). The primary cause of lower success rates in these lesions is side branch (SB) failure which could be due to dissection, flow disturbance, occlusion or significant residual stenosis (<xref rid="A31378R3" ref-type="bibr">3</xref>-<xref rid="A31378R10" ref-type="bibr">10</xref>). There are many stenting techniques which have been reported for the treatment of these lesions, with provisional stenting being the preferred and most widely used approach. This technique constitutes stent implantation in the main branch (MB) across the SB and stent implantation in the SB only if it is necessary. Although many operators have adopted this technique as their default strategy, certain anatomical considerations might suggest systematic double stenting as an initial approach (<xref rid="A31378R11" ref-type="bibr">11</xref>, <xref rid="A31378R12" ref-type="bibr">12</xref>). SB predilation is a controversial topic during provisional stenting because it could be associated with impairment of the SB flow and difficulty of access; however, its performance may be necessary for maintaining SB patency in some cases (<xref rid="A31378R13" ref-type="bibr">13</xref>). Pan et al. reported that SB predilation in true bifurcation lesions was associated with improved Thrombolysis in Myocardial Infarction (TIMI) flow after MB stenting and less need to subsequently treat the SB. In addition, if SB rewiring was needed, predilation did not hinder this maneuver (<xref rid="A31378R14" ref-type="bibr">14</xref>).</p></sec><sec id="sec139984"><title>2. Objectives</title><p>The present study aimed to assess the effect of SB predilation during provisional stenting in patients with true bifurcation lesions.</p></sec><sec id="sec139990"><title>3. Patients and Methods</title><sec id="sec139985"><title>3.1. Study Design</title><p>This randomized controlled trial was a single-center study on patients with true bifurcation lesions. They were randomly assigned provisional stenting with and without SB predilation, with a parallel design and allocation ratio of 1:1. The local ethics committee approved the trial design.</p></sec><sec id="sec139986"><title>3.2. Patient Population and Randomization</title><p>Five hundred and fifty patients were initially evaluated between September, 2013, and October, 2014. Patients were considered eligible if they met the following criteria: were older than 18 years of age; had chronic stable angina or acute coronary syndrome and an indication for coronary angiography and PCI; had a true bifurcation lesion according to the Medina classification ([1,1,1], [1,0,1], [0,1,1])); had undergone single vessel PCI; and the diameter of the main MB &#x02265; 2.5 mm, diameter of the SB &#x02265; 2 mm, and the length of stenosis in the SB &#x0003c; 5 mm. Patients were excluded due to the following criteria: inability to receive dual antiplatelet therapy; acute ST elevation MI and primary PCI; hemodynamic instability or cardiogenic shock at the time of presentation or during the hospital stay; left main lesion; multivessel PCI; inability to access the SB; the length of stenosis in the SB more than 5 mm beyond the ostium; untreated major complications during the procedure; and being pregnant. Randomization was performed based on the computerized balanced block randomization method in blocks of 4: 30 patients received SB predilation before the MB stenting and 30 had MB stenting without SB predilation. The sealed envelope technique was used to conceal the randomization.</p></sec><sec id="sec139987"><title>3.3. Procedural Protocol and Follow-Up</title><p>The study patients in both groups received the same routine preparation protocol for coronary angiography and PCI, including Aspirin and a 600 mg loading dose of Clopidogrel. Coronary angiography and PCI were performed according to standard routine. After wiring both the main and side branches, balloon angioplasty of the SB was performed in the predilation group using non-compliant balloons with sizes similar to the SB reference size at moderately high inflation pressures (14 - 18 atm). Predilation of the MB was performed if required. The diameter of the MB stent was chosen according to the diameter of the distal segment after the origin of the SB and the majority of the patients received a drug-eluting stent. Final kissing balloon dilation (FKB) dilation was considered in the presence of impaired SB flow (TIMI flow &#x0003c; 3) or SB ostial stenosis &#x0003e; 80%. In the case of continued impaired flow in the SB despite using FKB dilation, a double stenting technique was selected dependent on the anatomy of the bifurcation lesion.</p></sec><sec id="sec139988"><title>3.4. Primary and Secondary Endpoints</title><p>The primary endpoints of the study were the severity of stenosis, the occurrence of dissection in the ostial portion of the SB, and the TIMI flow of the SB after the MB stenting. Secondary endpoints were post-procedural cardiac Troponin-I (cTnI) rise, need for SB rewiring, time of rewiring, and need for final kissing balloon dilationand double stenting.</p></sec><sec id="sec139989"><title>3.5. Statistical Analysis</title><p>Results were presented as the mean &#x000b1; standard deviation (SD) for quantitative variables and were summarized by frequency (percentage) for categorical variables. Continuous variables were compared using the t test or the non-parametric Mann-Whitney U test whenever the data did not appear to have a normal distribution or when the assumption of equal variances was violated across the study groups. Categorical variables were compared using the chi-square test. For the statistical analysis, the statistical software SPSS version 16.0 for Windows (SPSS Inc., Chicago, IL) was used. A P value &#x02264; 0.05 was considered statistically significant.</p></sec></sec><sec id="sec139993"><title>4. Results</title><sec id="sec139991"><title>4.1. Baseline Characteristics</title><p>Of the 550 patients who were initially evaluated, 60 patients were subjected to random assignment of 30 to each group (<xref ref-type="fig" rid="fig26507">Figure 1</xref>). The patients were fairly comparable in terms of baseline demographic and clinical characteristics except for hypertension, which was more prevalent in the control group (<xref ref-type="table" rid="tbl36026">Table 1</xref>). The mean age of the patients was 57.3 years (range: 35 - 79 years) and 73% were male. There was no significant difference in the levels of pre-procedural cardiac Troponin-I between the two groups (P = 0.44). The patients were also homogenous regarding angiographic characteristics (<xref ref-type="table" rid="tbl36027">Table 2</xref>). The most common site of treated bifurcation lesions in both groups was the junction of the left anterior descending artery and the diagonal branches followed by bifurcation lesions of the left circumflex artery and obtuse marginal branches. Based on the Medina classification, the lesion type of 1, 1, 1 was the most common type seen in both groups (P = 0.94). The MB stents were comparable in length and diameter in both groups. The mean cTnI level was 0.19 &#x000b1; 0.56 in the predilation group and 0.43 &#x000b1; 1.62 in the control group before the procedure without a significant statistical difference (P = 0.44). The procedural characteristics of the patients are shown in <xref ref-type="table" rid="tbl36028">Table 3</xref>.</p><fig id="fig26507" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Flow of Study Patients</title></caption><graphic xlink:href="cardiovascmed-05-02-31378-i001"/></fig><table-wrap id="tbl36026" orientation="portrait" position="float"><label>Table 1.</label><caption><title> Baseline Demographic and Clinical Data of the Study Participants<sup><xref ref-type="table-fn" rid="fn38447">a</xref>,<xref ref-type="table-fn" rid="fn38448">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="vertical-align: bottom;text-align: left;" rowspan="1" colspan="1">Baseline Data</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Predilation</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Non-Predilation</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">P Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Age (Mean), y</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">58.9 &#x000b1; 12.7</td><td style="text-align: center;" rowspan="1" colspan="1">56.6 &#x000b1; 9.4</td><td style="text-align: center;" rowspan="1" colspan="1">0.42</td></tr><tr><td rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">0.55</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Male</td><td style="text-align: center;" rowspan="1" colspan="1">23 (76.7)</td><td style="text-align: center;" rowspan="1" colspan="1">21 (70)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Female</td><td style="text-align: center;" rowspan="1" colspan="1">7 (23.3)</td><td style="text-align: center;" rowspan="1" colspan="1">9 (30)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Risk factors</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Smoking</td><td style="text-align: center;" rowspan="1" colspan="1">7 (23.3)</td><td style="text-align: center;" rowspan="1" colspan="1">7 (23.3)</td><td style="text-align: center;" rowspan="1" colspan="1">0.9</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Hypertension</td><td style="text-align: center;" rowspan="1" colspan="1">8 (26.7)</td><td style="text-align: center;" rowspan="1" colspan="1">17 (56.7)</td><td style="text-align: center;" rowspan="1" colspan="1">0.01</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Dyslipidemia</td><td style="text-align: center;" rowspan="1" colspan="1">12 (40)</td><td style="text-align: center;" rowspan="1" colspan="1">11 (36.7)</td><td style="text-align: center;" rowspan="1" colspan="1">0.31</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Diabetes</td><td style="text-align: center;" rowspan="1" colspan="1">7 (23.3)</td><td style="text-align: center;" rowspan="1" colspan="1">11 (36.7)</td><td style="text-align: center;" rowspan="1" colspan="1">0.26</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Family history</td><td style="text-align: center;" rowspan="1" colspan="1">3 (10.3)</td><td style="text-align: center;" rowspan="1" colspan="1">2 (6.7)</td><td style="text-align: center;" rowspan="1" colspan="1">0.6</td></tr><tr><td rowspan="1" colspan="1">
<bold>Left ventricular function Mean (%)</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">44.5 &#x000b1; 9.41</td><td style="text-align: center;" rowspan="1" colspan="1">45.19 &#x000b1; 8.82</td><td style="text-align: center;" rowspan="1" colspan="1">0.77</td></tr><tr><td rowspan="1" colspan="1">
<bold>Clinical presentation</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Stable angina</td><td style="text-align: center;" rowspan="1" colspan="1">17 (56.6)</td><td style="text-align: center;" rowspan="1" colspan="1">22 (73.3)</td><td style="text-align: center;" rowspan="1" colspan="1">0.22</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">NSTEMI</td><td style="text-align: center;" rowspan="1" colspan="1">2 (6.7)</td><td style="text-align: center;" rowspan="1" colspan="1">3 (10.3)</td><td style="text-align: center;" rowspan="1" colspan="1">0.77</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">UA</td><td style="text-align: center;" rowspan="1" colspan="1">11 (36.7)</td><td style="text-align: center;" rowspan="1" colspan="1">5 (17.2)</td><td style="text-align: center;" rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">
<bold>Pre-procedural cTnI (&#x000b5;g/L)</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.19 &#x000b1; 0.56</td><td style="text-align: center;" rowspan="1" colspan="1">0.43 &#x000b1; 1.62</td><td style="text-align: center;" rowspan="1" colspan="1">0.44</td></tr></tbody></table><table-wrap-foot><fn id="fn38446"><p> Abbreviations: cTnI, cardiac Troponin-I; NSTEMI, non-ST-segment elevation MI; UA, unstable angina.</p></fn><fn id="fn38447"><p><sup>a</sup>(n = 30).</p></fn><fn id="fn38448"><p><sup>b</sup>Values are presented as No. (%) or Mean &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl36027" orientation="portrait" position="float"><label>Table 2.</label><caption><title> Angiographic Data of the Study Participants<sup><xref ref-type="table-fn" rid="fn38450">a</xref>,<xref ref-type="table-fn" rid="fn38451">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="vertical-align: bottom;text-align: left;" rowspan="1" colspan="1">Angiographic data</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Predilation</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Non-Predilation</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">P Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Lesion location</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">0.48</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">LAD-D</td><td style="text-align: center;" rowspan="1" colspan="1">24 (80)</td><td style="text-align: center;" rowspan="1" colspan="1">27 (90)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">LCX-OM</td><td style="text-align: center;" rowspan="1" colspan="1">5 (16.7)</td><td style="text-align: center;" rowspan="1" colspan="1">2 (6.7)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Distal RCA</td><td style="text-align: center;" rowspan="1" colspan="1">1 (3.3)</td><td style="text-align: center;" rowspan="1" colspan="1">1 (3.3)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Medina type</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">0.94</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">1,1,1</td><td style="text-align: center;" rowspan="1" colspan="1">22 (73.3)</td><td style="text-align: center;" rowspan="1" colspan="1">21 (70)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">1,0,1</td><td style="text-align: center;" rowspan="1" colspan="1">3 (10)</td><td style="text-align: center;" rowspan="1" colspan="1">3 (10)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">0,1,1</td><td style="text-align: center;" rowspan="1" colspan="1">5 (16.7)</td><td style="text-align: center;" rowspan="1" colspan="1">6 (20)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Main branch</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Lesion length, mm</td><td style="text-align: center;" rowspan="1" colspan="1">24.60 &#x000b1; 6.98</td><td style="text-align: center;" rowspan="1" colspan="1">24.33 &#x000b1; 7.80</td><td style="text-align: center;" rowspan="1" colspan="1">0.88</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Diameter, mm</td><td style="text-align: center;" rowspan="1" colspan="1">3.95 &#x000b1; 1.23</td><td style="text-align: center;" rowspan="1" colspan="1">3.27 &#x000b1; 1.16</td><td style="text-align: center;" rowspan="1" colspan="1">0.29(.99)</td></tr><tr><td rowspan="1" colspan="1">
<bold>Side branch</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Lesion length, mm</td><td style="text-align: center;" rowspan="1" colspan="1">4.43 &#x000b1; 1.74</td><td style="text-align: center;" rowspan="1" colspan="1">3.67 &#x000b1; 1.06</td><td style="text-align: center;" rowspan="1" colspan="1">0.06</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Diameter, mm</td><td style="text-align: center;" rowspan="1" colspan="1">2.33 &#x000b1; 0.09</td><td style="text-align: center;" rowspan="1" colspan="1">2.27 &#x000b1; 0.13</td><td style="text-align: center;" rowspan="1" colspan="1">0.93</td></tr></tbody></table><table-wrap-foot><fn id="fn38449"><p> Abbreviations: LAD-D, left anterior descending artery-diagonal branch; LCX-OM, left circumflex artery-obtuse marginal branch; RCA, right coronary artery.</p></fn><fn id="fn38450"><p><sup>a</sup>(n=30).</p></fn><fn id="fn38451"><p><sup>b</sup>Values are presented as No. (%) or Mean &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl36028" orientation="portrait" position="float"><label>Table 3.</label><caption><title> Procedural Characteristics of the Patients<sup><xref ref-type="table-fn" rid="fn38453">a</xref>,<xref ref-type="table-fn" rid="fn38454">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="vertical-align: bottom;text-align: left;" rowspan="1" colspan="1">Procedural data</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Predilation</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Non-Predilation</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">P Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Type of stent</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">0.77</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Drug-eluting</td><td style="text-align: center;" rowspan="1" colspan="1">30 (100)</td><td style="text-align: center;" rowspan="1" colspan="1">29 (96.6)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Bare-metal</td><td style="text-align: center;" rowspan="1" colspan="1">0</td><td style="text-align: center;" rowspan="1" colspan="1">1 (3.3)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Main branch stent</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Length</td><td style="text-align: center;" rowspan="1" colspan="1">28.53 &#x000b1; 7.25</td><td style="text-align: center;" rowspan="1" colspan="1">26.87 &#x000b1; 7.86</td><td style="text-align: center;" rowspan="1" colspan="1">0.32</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Diameter</td><td style="text-align: center;" rowspan="1" colspan="1">3.02 &#x000b1; 0.33</td><td style="text-align: center;" rowspan="1" colspan="1">2.96 &#x000b1; 0.34</td><td style="text-align: center;" rowspan="1" colspan="1">0.69</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Inflation pressure</td><td style="text-align: center;" rowspan="1" colspan="1">11.87 &#x000b1; 1.41</td><td style="text-align: center;" rowspan="1" colspan="1">12.13 &#x000b1; 1.48</td><td style="text-align: center;" rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">
<bold>Side branch</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Dissection</td><td style="text-align: center;" rowspan="1" colspan="1">(16.7)</td><td style="text-align: center;" rowspan="1" colspan="1">0</td><td style="text-align: center;" rowspan="1" colspan="1">0.07</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">TIMI &#x0003c; 3</td><td style="text-align: center;" rowspan="1" colspan="1">3 (10)</td><td style="text-align: center;" rowspan="1" colspan="1">1(6.7)</td><td style="text-align: center;" rowspan="1" colspan="1">0.34</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Ostial stenosis &#x0003e; 80%</td><td style="text-align: center;" rowspan="1" colspan="1">4 (13.3)</td><td style="text-align: center;" rowspan="1" colspan="1">8 (26.6)</td><td style="text-align: center;" rowspan="1" colspan="1">0.17</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Need to rewire</td><td style="text-align: center;" rowspan="1" colspan="1">15 (50)</td><td style="text-align: center;" rowspan="1" colspan="1">12 (40)</td><td style="text-align: center;" rowspan="1" colspan="1">0.43</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Rewiring time (mean), min</td><td style="text-align: center;" rowspan="1" colspan="1">2.87 &#x000b1; 1.69</td><td style="text-align: center;" rowspan="1" colspan="1">3.08 &#x000b1; 1.38</td><td style="text-align: center;" rowspan="1" colspan="1">0.72</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Final kissing inflation</td><td style="text-align: center;" rowspan="1" colspan="1">14 (46.7)</td><td style="text-align: center;" rowspan="1" colspan="1">11 (36.7)</td><td style="text-align: center;" rowspan="1" colspan="1">0.43</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Double stent strategy</td><td style="text-align: center;" rowspan="1" colspan="1">4 (13.3)</td><td style="text-align: center;" rowspan="1" colspan="1">0</td><td style="text-align: center;" rowspan="1" colspan="1">0.11</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">cTnI level, &#x000b5;g/L</td><td style="text-align: center;" rowspan="1" colspan="1">0.75 &#x000b1; 2.51</td><td style="text-align: center;" rowspan="1" colspan="1">0.55 &#x000b1; 1.12</td><td style="text-align: center;" rowspan="1" colspan="1">0.69</td></tr></tbody></table><table-wrap-foot><fn id="fn38452"><p> Abbreviations: cTnI, cardiac troponin-I; TIMI, thrombolysis in myocardial infarction.</p></fn><fn id="fn38453"><p><sup>a</sup>(n = 30).</p></fn><fn id="fn38454"><p><sup>b</sup>Values are presented as No. (%) or Mean &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec139992"><title>4.2. Primary and Secondary Outcomes</title><p>There was a trend toward higher rates of dissection in the ostium of the SB after predilation (16.7% vs. 0, P = 0.07). Impaired flow of the SB was seen in 10% of patients who received MB stenting after SB predilation; it occurred in 6.7% of patients who did not receive predilation (P = 0.34). The need for the SB rewiring and mean wiring time was not affected by the SB predilation. FKB dilation and the double stenting procedure were more common in the predilation group although the associations were not significantly important. The mean cTnI level was 0.75 &#x000b1; 2.51 in the predilation group and 0.55 &#x000b1; 1.12 in the control group after the procedure without a significant statistical difference (P = 0.69). Multivariable linear regression analysis (<xref ref-type="table" rid="tbl36029">Table 4</xref>) showed no difference between the predilation and non-predilation groups in mean percent of stenosis in the SB (beta = -2.673, SE = 3.222, P = 0.411). Also, the similar multivariable model (<xref ref-type="table" rid="tbl36030">Table 5</xref>) showed no difference between the two groups in the frequency of complications of final kissing balloon inflation (beta = 0.073, SE = 0.079, P = 0.363).</p><table-wrap id="tbl36029" orientation="portrait" position="float"><label>Table 4.</label><caption><title> Multivariable Linear Regression Analysis to Assess the Difference Between the Predilation and Non-Predilation Groups in Mean Percent of Stenosis in the Side Branch</title></caption><table frame="hsides" rules="groups"><thead><tr><th style="vertical-align: bottom;text-align: left;" rowspan="1" colspan="1">Item</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">B</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Std. Error</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">P Value</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Lower Bound</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Upper Bound</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Constant</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">70.478</td><td style="text-align: center;" rowspan="1" colspan="1">20.912</td><td style="text-align: center;" rowspan="1" colspan="1">0.002</td><td style="text-align: center;" rowspan="1" colspan="1">28.332</td><td style="text-align: center;" rowspan="1" colspan="1">112.624</td></tr><tr><td rowspan="1" colspan="1">
<bold>Predilation</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">-2.673</td><td style="text-align: center;" rowspan="1" colspan="1">3.222</td><td style="text-align: center;" rowspan="1" colspan="1">0.411</td><td style="text-align: center;" rowspan="1" colspan="1">-9.168</td><td style="text-align: center;" rowspan="1" colspan="1">3.821</td></tr><tr><td rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.368</td><td style="text-align: center;" rowspan="1" colspan="1">3.423</td><td style="text-align: center;" rowspan="1" colspan="1">0.915</td><td style="text-align: center;" rowspan="1" colspan="1">-6.530</td><td style="text-align: center;" rowspan="1" colspan="1">7.266</td></tr><tr><td rowspan="1" colspan="1">
<bold>Age</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.094</td><td style="text-align: center;" rowspan="1" colspan="1">0.144</td><td style="text-align: center;" rowspan="1" colspan="1">0.515</td><td style="text-align: center;" rowspan="1" colspan="1">-.195</td><td style="text-align: center;" rowspan="1" colspan="1">0.384</td></tr><tr><td rowspan="1" colspan="1">
<bold>Diabetes</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.859</td><td style="text-align: center;" rowspan="1" colspan="1">3.718</td><td style="text-align: center;" rowspan="1" colspan="1">0.818</td><td style="text-align: center;" rowspan="1" colspan="1">-6.635</td><td style="text-align: center;" rowspan="1" colspan="1">8.353</td></tr><tr><td rowspan="1" colspan="1">
<bold>Hypertension</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">4.796</td><td style="text-align: center;" rowspan="1" colspan="1">3.565</td><td style="text-align: center;" rowspan="1" colspan="1">0.185</td><td style="text-align: center;" rowspan="1" colspan="1">-2.389</td><td style="text-align: center;" rowspan="1" colspan="1">11.982</td></tr><tr><td rowspan="1" colspan="1">
<bold>Dyslipidemia</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.229</td><td style="text-align: center;" rowspan="1" colspan="1">4.154</td><td style="text-align: center;" rowspan="1" colspan="1">0.956</td><td style="text-align: center;" rowspan="1" colspan="1">-8.143</td><td style="text-align: center;" rowspan="1" colspan="1">8.601</td></tr><tr><td rowspan="1" colspan="1">
<bold>Smoking</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">1.001</td><td style="text-align: center;" rowspan="1" colspan="1">3.911</td><td style="text-align: center;" rowspan="1" colspan="1">0.799</td><td style="text-align: center;" rowspan="1" colspan="1">-6.881</td><td style="text-align: center;" rowspan="1" colspan="1">8.883</td></tr><tr><td rowspan="1" colspan="1">
<bold>Family history</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">-9.991</td><td style="text-align: center;" rowspan="1" colspan="1">5.081</td><td style="text-align: center;" rowspan="1" colspan="1">0.056</td><td style="text-align: center;" rowspan="1" colspan="1">-20.232</td><td style="text-align: center;" rowspan="1" colspan="1">0.250</td></tr><tr><td rowspan="1" colspan="1">
<bold>Ejection fraction</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.055</td><td style="text-align: center;" rowspan="1" colspan="1">0.174</td><td style="text-align: center;" rowspan="1" colspan="1">0.753</td><td style="text-align: center;" rowspan="1" colspan="1">-0.296</td><td style="text-align: center;" rowspan="1" colspan="1">0.407</td></tr></tbody></table></table-wrap><table-wrap id="tbl36030" orientation="portrait" position="float"><label>Table 5.</label><caption><title> Multivariable Linear Regression Analysis to Assess the Difference Between the Predilation and Non-Predilation Groups in the Frequency of the Complications of Final Kissing Balloon Inflation</title></caption><table frame="hsides" rules="groups"><thead><tr><th style="vertical-align: bottom;text-align: left;" rowspan="1" colspan="1">Item</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">B</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Std. Error</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">P Value</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Lower Bound</th><th style="vertical-align: bottom;" rowspan="1" colspan="1">Upper Bound</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Constant </bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">1.852</td><td style="text-align: center;" rowspan="1" colspan="1">0.510</td><td style="text-align: center;" rowspan="1" colspan="1">0.001</td><td style="text-align: center;" rowspan="1" colspan="1">0.820</td><td style="text-align: center;" rowspan="1" colspan="1">2.883</td></tr><tr><td rowspan="1" colspan="1">
<bold>Predilation</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.073</td><td style="text-align: center;" rowspan="1" colspan="1">0.079</td><td style="text-align: center;" rowspan="1" colspan="1">0.363</td><td style="text-align: center;" rowspan="1" colspan="1">-0.087</td><td style="text-align: center;" rowspan="1" colspan="1">0.233</td></tr><tr><td rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">-0.022</td><td style="text-align: center;" rowspan="1" colspan="1">0.082</td><td style="text-align: center;" rowspan="1" colspan="1">0.792</td><td style="text-align: center;" rowspan="1" colspan="1">-0.188</td><td style="text-align: center;" rowspan="1" colspan="1">0.144</td></tr><tr><td rowspan="1" colspan="1">
<bold>Age</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">7.950</td><td style="text-align: center;" rowspan="1" colspan="1">0.003</td><td style="text-align: center;" rowspan="1" colspan="1">0.998</td><td style="text-align: center;" rowspan="1" colspan="1">-0.007</td><td style="text-align: center;" rowspan="1" colspan="1">0.007</td></tr><tr><td rowspan="1" colspan="1">
<bold>Diabetes</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.058</td><td style="text-align: center;" rowspan="1" colspan="1">0.090</td><td style="text-align: center;" rowspan="1" colspan="1">0.523</td><td style="text-align: center;" rowspan="1" colspan="1">-0.123</td><td style="text-align: center;" rowspan="1" colspan="1">0.239</td></tr><tr><td rowspan="1" colspan="1">
<bold>Hypertension</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">-0.111</td><td style="text-align: center;" rowspan="1" colspan="1">0.088</td><td style="text-align: center;" rowspan="1" colspan="1">0.216</td><td style="text-align: center;" rowspan="1" colspan="1">-0.288</td><td style="text-align: center;" rowspan="1" colspan="1">0.067</td></tr><tr><td rowspan="1" colspan="1">
<bold>Dyslipidemia</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.029</td><td style="text-align: center;" rowspan="1" colspan="1">0.104</td><td style="text-align: center;" rowspan="1" colspan="1">0.782</td><td style="text-align: center;" rowspan="1" colspan="1">-0.182</td><td style="text-align: center;" rowspan="1" colspan="1">0.240</td></tr><tr><td rowspan="1" colspan="1">
<bold>Smoking</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">-0.105</td><td style="text-align: center;" rowspan="1" colspan="1">0.094</td><td style="text-align: center;" rowspan="1" colspan="1">0.274</td><td style="text-align: center;" rowspan="1" colspan="1">-0.295</td><td style="text-align: center;" rowspan="1" colspan="1">0.086</td></tr><tr><td rowspan="1" colspan="1">
<bold>Family history</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0.220</td><td style="text-align: center;" rowspan="1" colspan="1">0.133</td><td style="text-align: center;" rowspan="1" colspan="1">0.105</td><td style="text-align: center;" rowspan="1" colspan="1">-0.048</td><td style="text-align: center;" rowspan="1" colspan="1">0.488</td></tr><tr><td rowspan="1" colspan="1">
<bold>Ejection fraction</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">-0.004</td><td style="text-align: center;" rowspan="1" colspan="1">0.004</td><td style="text-align: center;" rowspan="1" colspan="1">0.285</td><td style="text-align: center;" rowspan="1" colspan="1">-0.013</td><td style="text-align: center;" rowspan="1" colspan="1">0.004</td></tr></tbody></table></table-wrap></sec></sec><sec id="sec139996"><title>5. Discussion</title><p>In the present clinical trial, the procedural consequences of SB predilation in provisional stenting of true bifurcation lesions were assessed. This study showed that the strategy of SB predilation has no significant effect on the outcome of the procedure including SB dissection, ostial stenosis after MB stenting, impairment of flow, rise in cardiac enzymes, need for rewiring, time of rewiring, and the rate of FKB inflation and double stenting. Instead, it seems there is a trend toward unfavorable results from predilation such as more common dissections in the SB ostium and impairment of flow, as well as a need for more complicated procedures. Even though it numerically reduced the severity of ostial stenosis of the SB after MB stenting and the time for rewiring of the SB, this was not associated with significant improvement of the final outcome. Although this study was not substantive due to the small number of participants, the results were similar to those of other studies. To date, there are not many studies comparing the effects of SB predilation on the outcome of PCI in true bifurcation lesions. The majority of studies have investigated the results of different types of stenting procedures without looking at initial treatment of the SB. There are three related studies currently available. In a study on provisional stenting of the left main bifurcation, SB predilation was associated with higher rates of FKB dilation and the double stent technique. The rates of long-term target vessel failure and revascularization were also higher in this group (<xref rid="A31378R15" ref-type="bibr">15</xref>). The results of this study seem to be affected by various factors, such as being non-randomized and the performance of predilation on more complex SB anatomies. The only other randomized trial on this topic was performed by Pan et al. (<xref rid="A31378R14" ref-type="bibr">14</xref>). It showed improved TIMI flow of the predilated SBs and less need to treat the SB after MB stenting. However, SB predilation had no significant effect on the final outcomes of the patients. In this study, post-dilation of the SBs was performed in the case of SB TIMI flow &#x0003c; 3 and SB ostial stenosis &#x0003e; 50%. Given the performance of this study on true bifurcation lesions which is defined as the presence of ostial stenosis &#x0003e; 50%, one can assume that all the lesions needed post-dilation. As a result, the final outcomes might be affected by SB post-dilation even in the non-predilation group (<xref rid="A31378R14" ref-type="bibr">14</xref>). In our study, further interventions were required with stricter criteria: the occurrence of TIMI flow &#x0003c; 3 and the presence of ostial stenosis &#x0003e; 80% after MB stenting, a practice which is more in accord with real-world practice. It offers the opportunity to best compare the consequences of SB predilation against non-predilation. In addition, different techniques of SB predilation are used by different operators and could result in different consequences. Although there is scarcity of data regarding the effects of SB predilation in the treatment of bifurcation lesions, our results were in accordance with available data, and have led us to the consensus that this procedure should be avoided in routine practice.</p><sec id="sec139994"><title>5.1. Limitations</title><p>The first and foremost limitation of this study was that it did not involve a significant population due to the small number of the participants. Also, visual estimation of the stenoses was used in this study, rather than quantitative coronary measurements. In addition, we did not use fractional flow reserve for evaluating the significance of SB ostial lesions before and after the procedure.</p></sec><sec id="sec139995"><title>5.2. Conclusions</title><p>Though limited due to the low number of participants, this study gave results that were similar to those of other studies on this issue. It seems that routine SB predilation is not necessarily associated with better angiographic results or ease of the procedure. Instead, it might result in the occurrence of more dissection and need for more complex procedures. Still, there are some complex ostial lesions of the SB which could benefit from predilation.</p></sec></sec></body><back><ack><p>The authors would like to thank Dr. Hooman Bakhshandeh for his critical review of the manuscript.</p></ack><fn-group><fn id="afn45377" fn-type="other"><p><bold>Authors&#x02019; Contribution:</bold>Hamidreza Sanati, Majid Hajikarimi, Ali zahedmehr and Mohammadmehdi Peighambari developed the study concept and designed the study. Majid Hajikarimi and Parham Sadeghipour were in charge of acquisition of data. Hamidreza Sanati, Majid Hajikarimi and Mohammadmehdi Peighambari analyzed and interpreted data. Ata Firouzi and Reza Kiani were in charge of drafting the manuscript. Siamak kazemi Asl revised the article. Hamidreza Sanati was in charge of statistical analysis. The study was technically supported by Mohammadmehdi Peighambari. The study was supervised by Mohammadmehdi Peighambari and Farshad Shakerian.</p></fn><fn id="afn45378" fn-type="supported-by"><p><bold>Funding/Support:</bold>This study did not receive any funding or support.</p></fn></fn-group><ref-list><title>References</title><ref id="A31378R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakura</surname><given-names>T</given-names></name><name><surname>Karino</surname><given-names>T</given-names></name></person-group><article-title>Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries.</article-title><source>Circ Res.</source><year>1990</year><volume>66</volume><issue>4</issue><fpage>1045</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">2317887</pub-id></element-citation></ref><ref id="A31378R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dauerman</surname><given-names>HL</given-names></name><name><surname>Higgins</surname><given-names>PJ</given-names></name><name><surname>Sparano</surname><given-names>AM</given-names></name><name><surname>Gibson</surname><given-names>CM</given-names></name><name><surname>Garber</surname><given-names>GR</given-names></name><name><surname>Carrozza</surname><given-names>JP</given-names></name><etal>et al.</etal></person-group><article-title>Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions.</article-title><source>J Am Coll Cardiol.</source><year>1998</year><volume>32</volume><issue>7</issue><fpage>1845</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(98)00488-4</pub-id><pub-id pub-id-type="pmid">9857861</pub-id></element-citation></ref><ref id="A31378R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>B</given-names></name><name><surname>Gruentzig</surname><given-names>AR</given-names></name><name><surname>King</surname><given-names>SB</given-names></name><name><surname>Douglas</surname><given-names>JS</given-names></name><name><surname>Hollman</surname><given-names>J</given-names></name><name><surname>Ischinger</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Risk of side branch occlusion during coronary angioplasty.</article-title><source>Am J Cardiol.</source><year>1984</year><volume>53</volume><issue>1</issue><fpage>10</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/0002-9149(84)90675-1</pub-id><pub-id pub-id-type="pmid">6229173</pub-id></element-citation></ref><ref id="A31378R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>JS</given-names></name><name><surname>Baim</surname><given-names>DS</given-names></name><name><surname>Sipperly</surname><given-names>ME</given-names></name><name><surname>McCabe</surname><given-names>CH</given-names></name><name><surname>Lorell</surname><given-names>BH</given-names></name></person-group><article-title>Salvage of branch vessels during bifurcation lesion angioplasty: acute and long-term follow-up.</article-title><source>Cathet Cardiovasc Diagn.</source><year>1991</year><volume>22</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1995167</pub-id></element-citation></ref><ref id="A31378R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melikian</surname><given-names>N</given-names></name><name><surname>Di Mario</surname><given-names>C</given-names></name></person-group><article-title>Treatment of bifurcation coronary lesions: a review of current techniques and outcome.</article-title><source>J Interv Cardiol.</source><year>2003</year><volume>16</volume><issue>6</issue><fpage>507</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">14632948</pub-id></element-citation></ref><ref id="A31378R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Nishida</surname><given-names>T</given-names></name><name><surname>Adamian</surname><given-names>MG</given-names></name><name><surname>Briguori</surname><given-names>C</given-names></name><name><surname>Vaghetti</surname><given-names>M</given-names></name><name><surname>Corvaja</surname><given-names>N</given-names></name><etal>et al.</etal></person-group><article-title>Bifurcation lesions: two stents versus one stent-immediate and follow-up results.</article-title><source>J Am Coll Cardiol.</source><year>2000</year><volume>35</volume><issue>5</issue><fpage>1145</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(00)00534-9</pub-id><pub-id pub-id-type="pmid">10758954</pub-id></element-citation></ref><ref id="A31378R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildick-Smith</surname><given-names>D</given-names></name><name><surname>de Belder</surname><given-names>AJ</given-names></name><name><surname>Cooter</surname><given-names>N</given-names></name><name><surname>Curzen</surname><given-names>NP</given-names></name><name><surname>Clayton</surname><given-names>TC</given-names></name><name><surname>Oldroyd</surname><given-names>KG</given-names></name><etal>et al.</etal></person-group><article-title>Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.</article-title><source>Circulation.</source><year>2010</year><volume>121</volume><issue>10</issue><fpage>1235</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.888297</pub-id><pub-id pub-id-type="pmid">20194880</pub-id></element-citation></ref><ref id="A31378R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>RA</given-names></name><name><surname>Moussa</surname><given-names>ID</given-names></name></person-group><article-title>Percutaneous treatment of coronary bifurcation lesions in the era of drug-eluting stents.</article-title><source>Minerva Cardioangiol.</source><year>2006</year><volume>54</volume><issue>5</issue><fpage>577</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">17019395</pub-id></element-citation></ref><ref id="A31378R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burzotta</surname><given-names>F</given-names></name><name><surname>Cook</surname><given-names>B</given-names></name><name><surname>Iaizzo</surname><given-names>PA</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Louvard</surname><given-names>Y</given-names></name><name><surname>Latib</surname><given-names>A</given-names></name></person-group><article-title>Coronary bifurcations as you have never seen them: the Visible Heart&#x000ae; Laboratory bifurcation programme.</article-title><source>EuroIntervention.</source><year>2015</year><volume>11</volume><issue>V</issue><fpage>V40</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">25983169</pub-id></element-citation></ref><ref id="A31378R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latib</surname><given-names>A</given-names></name><name><surname>Colombo</surname><given-names>A</given-names></name><name><surname>Sangiorgi</surname><given-names>GM</given-names></name></person-group><article-title>Bifurcation stenting: current strategies and new devices.</article-title><source>Heart.</source><year>2009</year><volume>95</volume><issue>6</issue><fpage>495</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1136/hrt.2008.150391</pub-id><pub-id pub-id-type="pmid">18812408</pub-id></element-citation></ref><ref id="A31378R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latib</surname><given-names>A</given-names></name><name><surname>Moussa</surname><given-names>I</given-names></name><name><surname>Sheiban</surname><given-names>I</given-names></name><name><surname>Colombo</surname><given-names>A</given-names></name></person-group><article-title>When are two stents needed? Which technique is the best? How to perform?</article-title><source>EuroIntervention.</source><year>2010</year><volume>6</volume><issue>J</issue><fpage>J81</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21930497</pub-id></element-citation></ref><ref id="A31378R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefevre</surname><given-names>T</given-names></name><name><surname>Louvard</surname><given-names>Y</given-names></name><name><surname>Morice</surname><given-names>MC</given-names></name><name><surname>Dumas</surname><given-names>P</given-names></name><name><surname>Loubeyre</surname><given-names>C</given-names></name><name><surname>Benslimane</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Stenting of bifurcation lesions: Classification, treatments, and results.</article-title><source>Catheter Cardiovasc Interv.</source><year>2000</year><volume>49</volume><issue>3</issue><fpage>274</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1002/(sici)1522-726x(200003)49:3&#x0003c;274::aid-ccd11&#x0003e;3.0.co;2-n</pub-id><pub-id pub-id-type="pmid">10700058</pub-id></element-citation></ref><ref id="A31378R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildick-Smith</surname><given-names>D</given-names></name><name><surname>Lassen</surname><given-names>JF</given-names></name><name><surname>Albiero</surname><given-names>R</given-names></name><name><surname>Lefevre</surname><given-names>T</given-names></name><name><surname>Darremont</surname><given-names>O</given-names></name><name><surname>Pan</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Consensus from the 5th European Bifurcation Club meeting.</article-title><source>EuroIntervention.</source><year>2010</year><volume>6</volume><issue>1</issue><fpage>34</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20542795</pub-id></element-citation></ref><ref id="A31378R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>M</given-names></name><name><surname>Medina</surname><given-names>A</given-names></name><name><surname>Romero</surname><given-names>M</given-names></name><name><surname>Ojeda</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Suarez de Lezo</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>Assessment of side branch predilation before a provisional T-stent strategy for bifurcation lesions. A randomized trial.</article-title><source>Am Heart J.</source><year>2014</year><volume>168</volume><issue>3</issue><fpage>374</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2014.05.014</pub-id><pub-id pub-id-type="pmid">25173550</pub-id></element-citation></ref><ref id="A31378R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>PS</given-names></name><name><surname>Song</surname><given-names>YB</given-names></name><name><surname>Yang</surname><given-names>JH</given-names></name><name><surname>Hahn</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><etal>et al.</etal></person-group><article-title>Efecto en los resultados de la intervenci&#x000f3;n y los resultados cl&#x000ed;nicos a largo plazo de la predilataci&#x000f3;n de la rama lateral para lesiones coronarias en bifurcaci&#x000f3;n tratadas con la t&#x000e9;cnica de stent condicional.</article-title><source>Rev Esp Cardiol (Engl Ed.</source><year>2014</year><volume>67</volume><issue>10</issue><fpage>804</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.recesp.2014.01.033</pub-id><pub-id pub-id-type="pmid">25262126</pub-id></element-citation></ref></ref-list></back></article>